---
schema_version: "secwatch.filing_event.v1"
accession: "0000947871-24-000587"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:25:59.220293+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35B (~US$985M)

## Summary
- Cash purchase price of ~C$1.35B (US$985M) including net debt, funded with cash and debt.
- LifeLabs generates ~C$970M (US$710M) annual revenue; deal slightly dilutive to GAAP EPS but accretive to adjusted EPS in first 12 months.
- LifeLabs will retain its brand, Canadian HQ, and management; Quest to provide expertise and resources.
- Closing expected by end of 2024, subject to Canadian regulatory approvals and key customer consents.
- LifeLabs has >6,500 employees and is a leading Canadian community lab; existing reference relationship with Quest.

## SEC filing metadata
- accession: 0000947871-24-000587
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000094787124000587/0000947871-24-000587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000094787124000587/ss3544770_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000947871-24-000587
- JSON: https://secwatch.observer/filing/0000947871-24-000587.json
- Plain text: https://secwatch.observer/filing/0000947871-24-000587.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.